Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Elucidation of the Role of the Integrin-linked kinase Pathway in Matrix-Delivered Cell Transplantation

EF 2009-10

Résumé
Coronary artery disease is a leading cause of mortality and disability worldwide. The majority of patients with coronary disease are treated with drug therapy and, in advanced cases, interventional procedures or invasive surgery. These therapies aim to relieve symptoms and to slow the progression of the disease. However, many patients fail to respond to these treatments or are ineligible for surgical procedures. This has prompted intensive research aimed at developing safe and effective new therapies for this group of patients. One promising strategy is cell therapy. For example, the transplantation of special cells that have the ability to stimulate and to participate in new blood vessel growth which may lead to improved heart function. Unfortunately, clinical trials have revealed that low retention and low survival of these cells have limited the success of this therapy. Recent research using animal models has reported improvements in the retention and survival of the transplanted cells when they were delivered in a collagen matrix. The proposed study will examine how biomaterials can improve cell therapy for tissue regeneration. Specifically, we will test the hypothesis that this may occur in two ways. Firstly, through the release of cellular factors which promote blood vessel growth and tissue repair and secondly, by recruiting additional cells to the target site. If this project succeeds, we will have a better understanding of the mechanisms underlying enhanced matrix-delivered cell transplantation. This will allow more advances to be made in cell therapy, and bring us one step closer to improving the quality of life of the many who suffer from cardiovascular diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
201205
Name
Manthorp Emily A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Elucidation of the Role of the Integrin-linked kinase Pathway in Matrix-Delivered Cell Transplantation
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Angiogenesis; Biomaterials; Collagen; Endothelial Progenitor Cells; Integrin-Linked Kinase; Nitric Oxide
Abstract
Coronary artery disease is a leading cause of mortality and disability worldwide. The majority of patients with coronary disease are treated with drug therapy and, in advanced cases, interventional procedures or invasive surgery. These therapies aim to relieve symptoms and to slow the progression of the disease. However, many patients fail to respond to these treatments or are ineligible for surgical procedures. This has prompted intensive research aimed at developing safe and effective new therapies for this group of patients. One promising strategy is cell therapy. For example, the transplantation of special cells that have the ability to stimulate and to participate in new blood vessel growth which may lead to improved heart function. Unfortunately, clinical trials have revealed that low retention and low survival of these cells have limited the success of this therapy. Recent research using animal models has reported improvements in the retention and survival of the transplanted cells when they were delivered in a collagen matrix. The proposed study will examine how biomaterials can improve cell therapy for tissue regeneration. Specifically, we will test the hypothesis that this may occur in two ways. Firstly, through the release of cellular factors which promote blood vessel growth and tissue repair and secondly, by recruiting additional cells to the target site. If this project succeeds, we will have a better understanding of the mechanisms underlying enhanced matrix-delivered cell transplantation. This will allow more advances to be made in cell therapy, and bring us one step closer to improving the quality of life of the many who suffer from cardiovascular diseases.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Manthorp, Emily A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~